8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 17, 2018

THE CLOROX COMPANY
(Exact name of registrant as specified in its charter)

___________________

Delaware	1-07151	31-0595760
(State or other jurisdiction of	(Commission File Number)	(I.R.S. Employer
incorporation)		Identification No.)

1221 Broadway, Oakland, California 94612-1888
(Address of principal executive offices) (Zip code)

(510) 271-7000
(Registrant's telephone number, including area code)

Not applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ] Written communications pursuant to Rule 425 Under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02  Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b) and (e) On January 17, 2018, Stephen M. Robb, Executive Vice President – Chief Financial Officer of The Clorox Company (the “Company”), provided notice of his intention to retire from the Company on March 31, 2018, following 29 years of service with the Company. Mr. Robb will continue in an advisory capacity through the end of the fiscal year.

(c) On January 17, 2018, the Board of Directors (the “Board”) of the Company appointed Kevin Jacobsen, age 51, to be Senior Vice President – Chief Financial Officer, effective April 1, 2018.

Mr. Jacobsen is currently the Company’s Vice President – Financial Planning & Analysis, a position he has held since November 2011. In this role, he is responsible for providing leadership for financial planning and analysis across all of the Company’s existing businesses and for its business development efforts. Mr. Jacobsen joined the Company in 1995 and has held a number of senior leadership roles in the Company’s finance department over the years, including serving as the finance leader for the Specialty Division, the Product Supply Organization and various business units.

In connection with Mr. Jacobsen’s appointment, on January 19, 2018, the Management Development and Compensation Committee of the Board approved an increase in Mr. Jacobsen’s base salary to $500,000 and an increase in his short-term incentive target from 50% to 80% of his salary, effective as of April 1, 2018. In addition, on April 2, 2018, Mr. Jacobsen will receive stock options that have an aggregate fair value of $200,000, which will vest over four years, and performance shares with an aggregate target fair value of $200,000.

A copy of the press release announcing the future Chief Financial Officer changes is filed as Exhibit 99.1 hereto and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits.

See the Exhibit Index below.

EXHIBIT INDEX

Exhibit	Description
99.1	Press Release dated January 22, 2018, of The Clorox Company

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

		THE CLOROX COMPANY
Date:	January 22, 2018	By:	/s/ Laura Stein
		Executive Vice President –
		General Counsel and Corporate Affairs

EX-99.1

PRESS RELEASE

Clorox EVP – CFO Steve Robb to Retire; Kevin Jacobsen Named SVP – CFO

OAKLAND, Calif., Jan. 22, 2018 – The Clorox Company (NYSE:CLX) today announced the following changes:

Executive Vice President – Chief Financial Officer Stephen M. “Steve” Robb has announced his decision to retire from the company. Robb, who joined Clorox in 1989, has been the company’s chief financial officer since 2011 and a member of the company’s executive management committee, with responsibility for leading all aspects of Clorox’s financial activities, including accounting, reporting, internal controls, treasury, tax and investor relations. During his career with Clorox, Robb has overseen the company’s cost savings efforts, which have produced an average of $100 million in savings annually. During his tenure as CFO, Robb has helped the company deliver a strong track record of financial results and total shareholder returns, in part enabled by these cost savings. In 2017, he was selected by the San Francisco Business Times as the Bay Area CFO of the Year for a large public company.

“After 29 years with the company, Steve leaves a tremendous legacy of financial stewardship and discipline that has served the company and investors well and will contribute to the company for years to come,” said Chairman and CEO Benno Dorer. “We are grateful for his many years of service to the company and contributing greatly in his years as CFO. We thank him for his integrity, leadership and distinguished service.

"Steve will actively serve in his CFO role through March 31, and then continue in an advisory capacity through the end of the fiscal year,” Dorer continued. “Steve’s leadership, focus on total shareholder return and the timing of this announcement will ensure a smooth and orderly transition that will help us continue our focus on driving growth that is profitable, sustainable and responsible.”

Effective April 1, Kevin Jacobsen will succeed Robb and has been appointed senior vice president – chief financial officer and a member of the company’s executive management committee, reporting to CEO Dorer. Jacobsen, who joined Clorox in 1995, has served as Clorox’s vice president – Financial Planning & Analysis since November 2011. During his tenure at Clorox, he has held senior leadership roles in Finance across the company. In all of these assignments, Jacobsen has focused on developing and implementing business strategies that drive increased shareholder value. As CFO, Jacobsen will oversee all aspects of Clorox’s financial activities.

"Kevin brings strong leadership, insight and a deep understanding of Clorox’s financial model," Robb said. "He is the company’s finance lead on our Business Operations Leadership Team and has helped to drive the financial success we've achieved. I couldn’t be more pleased to be passing the baton to Kevin."

“Kevin’s appointment as CFO is a great example of our robust succession-planning process,” said Dorer. “He is a seasoned and thoughtful executive with more than 20 years of experience across the Clorox finance organization and brings deep experience and strategic continuity to the CFO role.”

Photos of and additional biographical information on Robb and Jacobsen are available at https://www.thecloroxcompany.com/who-we-are/corporate-governance/executive-team/

The Clorox Company

The Clorox Company (NYSE: CLX) is a leading multinational manufacturer and marketer of consumer and professional products with approximately 8,100 employees worldwide and fiscal year 2017 sales of $6 billion. Clorox markets some of the most trusted and recognized consumer brand names, including its namesake bleach and cleaning products; Pine-Sol^® cleaners; Liquid Plumr^® clog removers; Poett^® home care products; Fresh Step^® cat litter; Glad^® bags, wraps and containers; Kingsford^® charcoal; Hidden Valley^® dressings and sauces; Brita^® water-filtration products; Burt's Bees^® natural personal care products; and RenewLife^® digestive health products. The company also markets brands for professional services, including Clorox Healthcare® and Clorox Commercial Solutions^®. More than 80 percent of the company's sales are generated from brands that hold the No. 1 or No. 2 market share positions in their categories. For more information, visit TheCloroxCompany.com, including the Good Growth blog, and follow the company on Twitter at @CloroxCo.

Media Relations:
Aileen Zerrudo 510-271-7892, aileen.zerrudo@clorox.com or Kathryn Caulfield 510-271-7209, kathryn.caulfield@clorox.com

Investor Relations:

Joel Ramirez 510-271-3012, joel.ramirez@clorox.com; Lisah Burhan 510-271-3269, lisah.burhan@clorox.com or Steve Austenfeld 510-271-2270, steve.austenfeld@clorox.com

Page 1 of 1